Plasmodium infection prevents recurrence and metastasis of hepatocellular carcinoma potentially via inhibiting EMT
Abstract Background: Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer mortality worldwide and is characterized by a high rate of recurrence. We have previously reported Plasmodium infection inhibits tumor development and metastasis in a murine Lewis lung cancer model. In the current study, we aimed to examine the effects of Plasmodium infection on HCC metastasis and recurrence.Methods: Antitumor effects of Plasmodium infection were determined using two murine orthotopic HCC models, the non-resection model for investigating the effect of Plasmodium infection on liver tumor progression and metastasis, the resection model for investigating the effect of Plasmodium infection on the tumor recurrence after tumor was removed. Tumor tissues derived from tumor-bearing mice treated with or without Plasmodium infection were harvested after 15 days of tumor inoculation. The biomarkers related to epithelial-mesenchymal transition (EMT) and molecules associated with CCR10-mediated PI3K/Akt/GSK-3β/Snail pathway signaling were identified by qRT-PCR and western blot. Results: We found that Plasmodium infection significantly suppressed progression, recurrence and metastasis of HCC and prolonged the survival of tumor-bearing mice in both models. The expression levels of E-cadherin were significantly higher in Plasmodium treated group compared with those in control group, whereas the expression levels of Snail were significantly lower in the treated group than those in control group. Furthermore, Plasmodium infection inhibited the activation of Akt and GSK-3β in the tumor tissues by downregulating the expression of CCR10, thereby suppressing the accumulation of Snail and potentially contributed to the suppression of EMT and the prevention of tumor recurrence and metastasis.Conclusion: This study suggested that Plasmodium infection inhibited recurrence and metastasis, improved the prognosis of HCC potentially via suppression of CCR10‑mediated PI3K/Akt/GSK‑3β/Snail signaling, and prevention of EMT. These findings may be important in the development of novel therapy for HCC recurrence and metastasis especially for patients during the perioperative period.